These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 12044619)
1. Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS). Maier C; Hildebrandt J; Klinger R; Henrich-Eberl C; Lindena G; Pain; 2002 Jun; 97(3):223-233. PubMed ID: 12044619 [TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
3. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine. Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial. Chang AK; Bijur PE; Baccelieri A; Gallagher EJ Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935 [TBL] [Abstract][Full Text] [Related]
6. Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine. Kalso E; Simpson KH; Slappendel R; Dejonckheere J; Richarz U BMC Med; 2007 Dec; 5():39. PubMed ID: 18154644 [TBL] [Abstract][Full Text] [Related]
7. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Coluzzi PH; Schwartzberg L; Conroy JD; Charapata S; Gay M; Busch MA; Chavez J; Ashley J; Lebo D; McCracken M; Portenoy RK Pain; 2001 Mar; 91(1-2):123-30. PubMed ID: 11240084 [TBL] [Abstract][Full Text] [Related]
8. Analgesic efficacy and tolerability of intravenous morphine versus combined intravenous morphine and oxycodone in a 2-center, randomized, double-blind, pilot trial of patients with moderate to severe pain after total hip replacement. Joppich R; Richards P; Kelen R; Stern W; Zarghooni K; Otto C; Böhmer A; Petzke F; Treptau T; Lefering R; Bäthis H; Neugebauer E Clin Ther; 2012 Aug; 34(8):1751-60. PubMed ID: 22795613 [TBL] [Abstract][Full Text] [Related]
9. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Galer BS; Lee D; Ma T; Nagle B; Schlagheck TG Pain; 2005 Jun; 115(3):284-295. PubMed ID: 15911155 [TBL] [Abstract][Full Text] [Related]
10. Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study. Hamann S; Sloan P J Opioid Manag; 2007; 3(3):137-44. PubMed ID: 18027539 [TBL] [Abstract][Full Text] [Related]
11. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Mercadante S; Arcuri E; Tirelli W; Villari P; Casuccio A Tumori; 2002; 88(3):239-42. PubMed ID: 12195763 [TBL] [Abstract][Full Text] [Related]
13. Effects of IV morphine in central pain: a randomized placebo-controlled study. Attal N; Guirimand F; Brasseur L; Gaude V; Chauvin M; Bouhassira D Neurology; 2002 Feb; 58(4):554-63. PubMed ID: 11865132 [TBL] [Abstract][Full Text] [Related]
14. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial. Kopecky EA; Vaughn B; Lagasse S; O'Connor M Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725 [TBL] [Abstract][Full Text] [Related]
15. Methadone for neuropathic pain in adults. McNicol ED; Ferguson MC; Schumann R Cochrane Database Syst Rev; 2017 May; 5(5):CD012499. PubMed ID: 28514508 [TBL] [Abstract][Full Text] [Related]
16. Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continus. Peat S; Sweet P; Miah Y; Barklamb M; Larsen U Eur J Clin Pharmacol; 1999 Oct; 55(8):577-81. PubMed ID: 10541775 [TBL] [Abstract][Full Text] [Related]
17. APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty. Singla NK; Skobieranda F; Soergel DG; Salamea M; Burt DA; Demitrack MA; Viscusi ER Pain Pract; 2019 Sep; 19(7):715-731. PubMed ID: 31162798 [TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer. Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560 [TBL] [Abstract][Full Text] [Related]
19. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. Corli O; Floriani I; Roberto A; Montanari M; Galli F; Greco MT; Caraceni A; Kaasa S; Dragani TA; Azzarello G; Luzzani M; Cavanna L; Bandieri E; Gamucci T; Lipari G; Di Gregorio R; Valenti D; Reale C; Pavesi L; Iorno V; Crispino C; Pacchioni M; Apolone G; Ann Oncol; 2016 Jun; 27(6):1107-1115. PubMed ID: 26940689 [TBL] [Abstract][Full Text] [Related]